227 related articles for article (PubMed ID: 24662319)
1. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?
Laurberg P; Andersen SL
Eur J Endocrinol; 2014 Jul; 171(1):R13-20. PubMed ID: 24662319
[TBL] [Abstract][Full Text] [Related]
2. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
3. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
[TBL] [Abstract][Full Text] [Related]
4. Graves'-Basedow disease in pregnancy. New trends in the management and guidance to reduce the risk of birth defects caused by antithyroid drugs.
Laurberg P; Andersen SL
Nuklearmedizin; 2015; 54(3):106-11. PubMed ID: 26105719
[TBL] [Abstract][Full Text] [Related]
5. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
[TBL] [Abstract][Full Text] [Related]
6. Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.
Li H; Zheng J; Luo J; Zeng R; Feng N; Zhu N; Feng Q
PLoS One; 2015; 10(5):e0126610. PubMed ID: 25974033
[TBL] [Abstract][Full Text] [Related]
7. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study.
Andersen SL; Lönn S; Vestergaard P; Törring O
Eur J Endocrinol; 2017 Oct; 177(4):369-378. PubMed ID: 28780518
[TBL] [Abstract][Full Text] [Related]
8. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
Morales DR; Fonkwen L; Nordeng HME
Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
[TBL] [Abstract][Full Text] [Related]
9. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
Lo JC; Rivkees SA; Chandra M; Gonzalez JR; Korelitz JJ; Kuzniewicz MW
Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
Karras S; Tzotzas T; Kaltsas T; Krassas GE
Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hyperthyroidism in pregnancy and birth defects.
Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
[TBL] [Abstract][Full Text] [Related]
13. Severity of birth defects after propylthiouracil exposure in early pregnancy.
Andersen SL; Olsen J; Wu CS; Laurberg P
Thyroid; 2014 Oct; 24(10):1533-40. PubMed ID: 24963758
[TBL] [Abstract][Full Text] [Related]
14. Safety of antithyroid drugs in pregnancy: update and therapy implications.
Francis T; Francis N; Lazarus JH; Okosieme OE
Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
[No Abstract] [Full Text] [Related]
15. Antithyroid Drug Side Effects in the Population and in Pregnancy.
Andersen SL; Olsen J; Laurberg P
J Clin Endocrinol Metab; 2016 Apr; 101(4):1606-14. PubMed ID: 26815881
[TBL] [Abstract][Full Text] [Related]
16. Antithyroid Drug Use in Pregnancy and Birth Defects: Why Some Studies Find Clear Associations, and Some Studies Report None.
Laurberg P; Andersen SL
Thyroid; 2015 Nov; 25(11):1185-90. PubMed ID: 26359310
[TBL] [Abstract][Full Text] [Related]
17. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.
Song R; Lin H; Chen Y; Zhang X; Feng W
PLoS One; 2017; 12(7):e0180108. PubMed ID: 28671971
[TBL] [Abstract][Full Text] [Related]
18. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
19. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
[No Abstract] [Full Text] [Related]
20. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States.
Korelitz JJ; McNally DL; Masters MN; Li SX; Xu Y; Rivkees SA
Thyroid; 2013 Jun; 23(6):758-65. PubMed ID: 23194469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]